Researching long-term COVID-19 effects in non-hospitalised individuals

0 Saves · 2 Shares · 1 Comments Discussion

Grant Name

Funder

Medical Research Council (MRC) - United Kingdom

UK Research and Innovation (UKRI)

United Kingdom Government

Country or Region

United Kingdom

Research Field

Anxiety Disorders

Chronic Fatigue Syndrome

Chronic Obstructive Pulmonary Disease

COVID-19

Disease Control

Mental Health

Stress

Virology

Deadline

December 2, 2021 (Expired)

Grant Size

Up to £20 million is available to fund two or three proposals and a small number of study extensions which take a holistic approach. Projects can last up to three years.

Contact Info

ccf-ncov@nihr.ac.uk

Eligibility

Academic principal investigators applying for this call must be hosted by a UK institution which is eligible for UKRI funding. Applications from small and medium enterprises (SMEs) (including start-up or ‘spin-out’ companies), government arms length bodies, and NHS organisations (including NHS trusts and NHS foundation trusts), and equivalent UK authorities are also acceptable in alignment with NIHR funding policies, where these organisations are the lead applicant. An SME is defined as registered in the UK, having a staff headcount no greater than 250 and annual turnover no greater than €50 million (including start-up or spin-out companies). Companies must be registered on Companies House prior to being eligible for funding. Awards to UK-based, non-SME commercial entities will be also considered.

Description

Apply for funding for research into the causes (biological and environmental), mechanisms and management of the longer-term physical and mental health effects of COVID-19 in non-hospitalised individuals. There is now increasing medical evidence and patient testimony showing that a small but significant minority of people who contract and survive COVID-19 report chronic symptoms ranging from breathlessness, chronic fatigue, ‘brain fog’, anxiety and stress for months after initially falling ill. Example areas that the research may address include but are not limited to: determining whether long COVID is a distinct syndrome or a set of syndromes identifying whether an identifiable subgroup of symptoms exists determining the prevalence of long COVID understanding factors that increase or diminish the risk of long COVID, this might include viral titre, age, gender, ethnicity, socioeconomic status or comorbidities comparison with other cohorts, for example, seasonal influenza understanding the trajectory and how people experience long COVID over time including any biological, social or ecological interactions that impact on the severity of symptoms determining the pathogenesis of long COVID developing and assessing the effectiveness of approaches to reduce the risk of long COVID or interventions and therapies to address its impacts management of long COVID in primary care and social care settings. Eligibility Academic principal investigators applying for this call must be hosted by a UK institution which is eligible for UKRI funding. Applications from small and medium enterprises (SMEs) (including start-up or ‘spin-out’ companies), government arms length bodies, and NHS organisations (including NHS trusts and NHS foundation trusts), and equivalent UK authorities are also acceptable in alignment with NIHR funding policies, where these organisations are the lead applicant. An SME is defined as registered in the UK, having a staff headcount no greater than 250 and annual turnover no greater than €50 million (including start-up or spin-out companies). Companies must be registered on Companies House prior to being eligible for funding. Awards to UK-based, non-SME commercial entities will be also considered.

Website

https://mrc.ukri.org/funding/browse/long-term-effects-of-covid-19/researching-long-term-covid-19-effects-in-non-hospitalised-individuals/

Funding resources
Purdue Grant Writing Lab: Introduction to Grant Writing	Open Link
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal	Open Link